Clinitech Laboratory Ltd Changes Market Maker Amidst Restructuring
Clinitech Laboratory Ltd announced an approved change in its market maker, effective April 10, 2026. The Board of Directors passed a resolution via circulation on April 09, 2026, formalizing the transition.The company confirmed that the market maker is shifting from SVCM Securities Private Limited to Kalpalabdhi Financials Private Limited. This change is necessary because the existing market maker, SVCM Securities Private Limited, is discontinuing the market making segment due to its internal restructuring, effective April 09, 2026.
Following this transition, a tripartite agreement has been executed between Clinitech Laboratory Limited, Inventure Merchant Banker Services Private Limited, and Kalpalabdhi Financials Private Limited. This agreement concerns the market making arrangement.
The key details of the agreement are summarized below:
| Sr. No. | Particulars | Details |
|---|---|---|
| 1 | Name of parties to the agreement | a. Clinitech Laboratory Limited ('Company') b. Inventure Merchant Banker Services Private Limited ('Lead Manager') c. Kalpalabdhi Financials Private Limited ('Market Maker') |
| 2 | Reason | Change in market maker as existing market maker discontinued market making segment due to internal restructuring. |
| 3 | Nature of Agreement | Market Making Agreement |
| 4 | Date of execution of agreement | April 09, 2026 |
The appointment of the new market maker, Kalpalabdhi Financials Private Limited, will be effective from April 10, 2026.
Stock Price Movement
For Monday's close, Clinitech Laboratory Ltd settled at ₹35.00, capturing a 6.64% jump from its previous session. During the trading day, the shares remained completely locked, failing to move from the ₹35.00 intraday range.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.